Looking to complete a pivotal trial on a lumbar nucleus replacement device, 16-year-old Pioneer Surgical Technology Inc. has raised $15 million in Series B financing.
Pioneer Surgical’s CEO and Founder, Matt Songer M.D., has been trying to tell anyone who’ll listen that he’s got not one, but two potential game-changing biologic technologies in his portfolio.
SciQuest, Inc., the global leader empowering enterprises to realize the potential of strategic procurement, today announced that the company and president and CEO Stephen Wiehe were recognized by the North Carolina Technology Association (NCTA).
Simbionix USA Corporation is pleased to announce the completion of a Series C round of growth capital financing led by River Cities Capital Funds.
Fast-growing medical device company completes successful round.
Buyout augments existing business in Philadelphia, New York and Phoenix markets, adds new markets in Tucson, Melbourne, Fla., and San Antonio.
SciQuest, Inc., the global leader in helping academic, healthcare and research-centric organizations realize the potential of strategic procurement, today announced that the company was named the “Best Business Turnaround” in the 2008.
River Cities Capital Fund IV invests in Medplast and Harold Faig joins the newly combined company as CEO.
Financing to be used to expand portfolio of GI endoscopy products and services; EndoChoice.com to provide one-stop shopping for GI departments.
River Cities Capital Funds is pleased to announce an investment in NineSigma, the leading provider of open innovation (OI) solutions to global corporations.